Literature DB >> 24767874

Comparison of rhinovirus antibody titers in children with asthma exacerbations and species-specific rhinovirus infection.

Jua Iwasaki1, Wendy-Anne Smith1, Siew-Kim Khoo2, Joelene Bizzintino2, Guicheng Zhang3, Des W Cox2, Ingrid A Laing2, Peter N Le Souëf2, Wayne R Thomas1, Belinda J Hales4.   

Abstract

BACKGROUND: Asthma exacerbations are associated with human rhinovirus (HRV) infections, and more severe exacerbations are associated with HRV-C. We have previously shown that the HRV-C-specific antibody response is low in healthy adult sera and that most of the antibody to HRV-C is cross-reactive with HRV-A.
OBJECTIVES: To compare the antibody response to each HRV species in asthmatic and nonasthmatic children in whom the type of HRV infection was known.
METHODS: Total and specific IgG₁ binding to HRV viral capsid protein antigens of HRV-A, -B, and -C were tested in the plasma from nonasthmatic children (n = 47) and children presenting to the emergency department with asthma exacerbations (n = 96). HRV, found in most of the children at the time of their exacerbation (72%), was analyzed using molecular typing.
RESULTS: Asthmatic children had higher antibody responses to HRV. The titers specific to HRV-A, and to a lesser extent HRV-B, were higher than in nonasthmatic controls. The species-specific responses to HRV-C were markedly lower than titers to HRV-A and HRV-B in both asthmatic and nonasthmatic children (P < .001). The titers both at presentation and after convalescence were not associated with the HRV genotype detected during the exacerbation.
CONCLUSIONS: The higher total anti-HRV antibody titers of asthmatic children and their higher anti-HRV-A and -B titers show their development of a heightened antiviral immune response. The low species-specific HRV-C titers found in all groups, even when the virus was found, point to a different and possibly less efficacious immune response to this species.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Human rhinovirus; IgG(1) antibody; VP1; asthma exacerbation; children

Mesh:

Substances:

Year:  2014        PMID: 24767874     DOI: 10.1016/j.jaci.2014.03.014

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  20 in total

1.  Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C.

Authors:  Cibele M Gaido; Shane Stone; Abha Chopra; Wayne R Thomas; Peter N Le Souëf; Belinda J Hales
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

2.  Single-Cell Tracking Reveals a Role for Pre-Existing CCR5+ Memory Th1 Cells in the Control of Rhinovirus-A39 After Experimental Challenge in Humans.

Authors:  Lyndsey M Muehling; Ronald B Turner; Kenneth B Brown; Paul W Wright; James T Patrie; Sampo J Lahtinen; Markus J Lehtinen; William W Kwok; Judith A Woodfolk
Journal:  J Infect Dis       Date:  2018-01-17       Impact factor: 5.226

3.  Rhinovirus Species-Specific Antibodies Differentially Reflect Clinical Outcomes in Health and Asthma.

Authors:  Spyridon Megremis; Katarzyna Niespodziana; Clarissa Cabauatan; Paraskevi Xepapadaki; Marek L Kowalski; Tuomas Jartti; Claus Bachert; Susetta Finotto; Peter West; Sofia Stamataki; Anna Lewandowska-Polak; Heikki Lukkarinen; Nan Zhang; Theodor Zimmermann; Frank Stolz; Angela Neubauer; Mübeccel Akdis; Evangelos Andreakos; Rudolf Valenta; Nikolaos G Papadopoulos
Journal:  Am J Respir Crit Care Med       Date:  2018-12-15       Impact factor: 21.405

4.  Recurrent rhinovirus detections in children following a rhinovirus-induced wheezing exacerbation: A retrospective study.

Authors:  Sofie Halmø Hürdum; Guicheng Zhang; Siew-Kim Khoo; Joelene Bizzintino; Kimberley Marie Franks; Katie Lindsay; Anthony David Keil; Desmond William Cox; Jack Goldblatt; Yury Alexandrovich Bochkov; James Gern; Charlotte Suppli Ulrik; Peter Neils Le Souëf; Ingrid Alisa Laing
Journal:  Int J Pediatr Child Health       Date:  2015-08

5.  Circulating Memory CD4+ T Cells Target Conserved Epitopes of Rhinovirus Capsid Proteins and Respond Rapidly to Experimental Infection in Humans.

Authors:  Lyndsey M Muehling; Duy T Mai; William W Kwok; Peter W Heymann; Anna Pomés; Judith A Woodfolk
Journal:  J Immunol       Date:  2016-09-02       Impact factor: 5.422

Review 6.  House Dust Mite Allergens: New Discoveries and Relevance to the Allergic Patient.

Authors:  Wayne R Thomas
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

Review 7.  Predicting Severe Asthma Exacerbations in Children.

Authors:  Sandeep Puranik; Erick Forno; Andrew Bush; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2017-04-01       Impact factor: 21.405

8.  Enhanced Neutralizing Antibody Responses to Rhinovirus C and Age-Dependent Patterns of Infection.

Authors:  Timothy Choi; Mark Devries; Leonard B Bacharier; William Busse; Carlos A Camargo; Robyn Cohen; Gregory P Demuri; Michael D Evans; Anne M Fitzpatrick; Peter J Gergen; Kristine Grindle; Rebecca Gruchalla; Tina Hartert; Kohei Hasegawa; Gurjit K Khurana Hershey; Patrick Holt; Kiara Homil; Tuomas Jartti; Meyer Kattan; Carolyn Kercsmar; Haejin Kim; Ingrid A Laing; Petra LeBeau; Kristine E Lee; Peter N Le Souëf; Andrew Liu; David T Mauger; Carole Ober; Tressa Pappas; Shilpa J Patel; Wanda Phipatanakul; Jacqueline Pongracic; Christine Seroogy; Peter D Sly; Christopher Tisler; Ellen R Wald; Robert Wood; Ronald Gangnon; Daniel J Jackson; Robert F Lemanske; James E Gern; Yury A Bochkov
Journal:  Am J Respir Crit Care Med       Date:  2021-04-01       Impact factor: 30.528

9.  Developing Strategies to Treat Asthma Exacerbations Caused by Rhinovirus.

Authors:  Peter W Heymann
Journal:  EBioMedicine       Date:  2014-12-31       Impact factor: 8.143

10.  The Argentina Premature Asthma and Respiratory Team (APART): objectives, design, and recruitment results of a prospective cohort study of viruses and wheezing in very low birth weight infants.

Authors:  Tatyana Plachco; Romina Libster; Jodell E Linder; Lucrecia Bossi; Norma Aspres; Gabriela Bauer; John V Williams; Fernando P Polack; E Kathryn Miller
Journal:  Adv Pediatr Res       Date:  2014-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.